-
1
-
-
41349099104
-
Cancer statistics, 2008
-
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
-
(2008)
CA Cancer J Clin
, vol.58
, pp. 71-96
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
-
3
-
-
0031867690
-
Diet, nutrition, and prostate cancer
-
Clinton SK, Giovannucci E. Diet, nutrition, and prostate cancer. Annu Rev Nutr 1998;18:413-440.
-
(1998)
Annu Rev Nutr
, vol.18
, pp. 413-440
-
-
Clinton, S.K.1
Giovannucci, E.2
-
4
-
-
12344285031
-
Macronutrients, fatty acids, cholesterol and prostate cancer risk
-
Bidoli E, Talamini R, Bosetti C, et al. Macronutrients, fatty acids, cholesterol and prostate cancer risk. Ann Oncol 2005;16:152-157.
-
(2005)
Ann Oncol
, vol.16
, pp. 152-157
-
-
Bidoli, E.1
Talamini, R.2
Bosetti, C.3
-
5
-
-
22944459874
-
Prostate cancer and inositol hexaphosphate: Efficacy and mechanisms
-
Singh RP, Agarwal R. Prostate cancer and inositol hexaphosphate: Efficacy and mechanisms. Anticancer Res 2005;25: 2891-2903.
-
(2005)
Anticancer Res
, vol.25
, pp. 2891-2903
-
-
Singh, R.P.1
Agarwal, R.2
-
6
-
-
0034492496
-
Role of diet modification in cancer prevention
-
Abdulla M, Gruber P. Role of diet modification in cancer prevention. Biofactors 2000;12:45-51.
-
(2000)
Biofactors
, vol.12
, pp. 45-51
-
-
Abdulla, M.1
Gruber, P.2
-
7
-
-
32944481144
-
Chemoprevention of prostate cancer
-
Klein EA. Chemoprevention of prostate cancer. Annu Rev Med 2006;57:49-63.
-
(2006)
Annu Rev Med
, vol.57
, pp. 49-63
-
-
Klein, E.A.1
-
8
-
-
33751081567
-
Mechanisms of action of novel agents for prostate cancer chemoprevention
-
Singh RP, Agarwal R. Mechanisms of action of novel agents for prostate cancer chemoprevention. Endocr Relat Cancer 2006;13:751-778.
-
(2006)
Endocr Relat Cancer
, vol.13
, pp. 751-778
-
-
Singh, R.P.1
Agarwal, R.2
-
9
-
-
34547657069
-
Chemoprevention of prostate cancer: Agents and study designs
-
Thompson IM. Chemoprevention of prostate cancer: Agents and study designs. J Urol 2007;178:S9-S13.
-
(2007)
J Urol
, vol.178
-
-
Thompson, I.M.1
-
10
-
-
0035102946
-
Rice-bran products: Phytonutrients with potential applications in preventive and clinical medicine
-
Jariwalla RJ. Rice-bran products: Phytonutrients with potential applications in preventive and clinical medicine. Drugs Exp Clin Res 2001;27:17-26.
-
(2001)
Drugs Exp Clin Res
, vol.27
, pp. 17-26
-
-
Jariwalla, R.J.1
-
12
-
-
0242526048
-
Cancer inhibition by inositol hexaphosphate (IP6) and inositol: From laboratory to clinic
-
Vucenik I, Shamsuddin AM. Cancer inhibition by inositol hexaphosphate (IP6) and inositol: From laboratory to clinic. J Nutr 2003;133:3778S-3784S.
-
(2003)
J Nutr
, vol.133
-
-
Vucenik, I.1
Shamsuddin, A.M.2
-
13
-
-
33750846875
-
Protection against cancer by dietary IP6 and inositol
-
Vucenik I, Shamsuddin AM. Protection against cancer by dietary IP6 and inositol. Nutr Cancer 2006;55:109-125.
-
(2006)
Nutr Cancer
, vol.55
, pp. 109-125
-
-
Vucenik, I.1
Shamsuddin, A.M.2
-
14
-
-
0023936256
-
Suppression of large intestinal cancer in F344 rats by inositol hexaphosphate
-
Shamsuddin AM, Elsayed AM, Ullah A. Suppression of large intestinal cancer in F344 rats by inositol hexaphosphate. Carcinogenesis 1988;9:577-580.
-
(1988)
Carcinogenesis
, vol.9
, pp. 577-580
-
-
Shamsuddin, A.M.1
Elsayed, A.M.2
Ullah, A.3
-
15
-
-
0024517059
-
Inositol hexaphosphate inhibits large intestinal cancer in F344 rats 5 months after induction by azoxymethane
-
Shamsuddin AM, Ullah A. Inositol hexaphosphate inhibits large intestinal cancer in F344 rats 5 months after induction by azoxymethane. Carcinogenesis 1989;10:625-626.
-
(1989)
Carcinogenesis
, vol.10
, pp. 625-626
-
-
Shamsuddin, A.M.1
Ullah, A.2
-
16
-
-
0029122135
-
Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells
-
Shamsuddin AM, Yang GY. Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells. Carcinogenesis 1995;16:1975-1979.
-
(1995)
Carcinogenesis
, vol.16
, pp. 1975-1979
-
-
Shamsuddin, A.M.1
Yang, G.Y.2
-
17
-
-
6944232245
-
Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells
-
Agarwal C, Dhanalakshmi S, Singh RP, Agarwal R. Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells. Neoplasia 2004;6:646-659.
-
(2004)
Neoplasia
, vol.6
, pp. 646-659
-
-
Agarwal, C.1
Dhanalakshmi, S.2
Singh, R.P.3
Agarwal, R.4
-
18
-
-
0037360095
-
Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: Modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes
-
Singh RP, Agarwal C, Agarwal R. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: Modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes. Carcinogenesis 2003;24:555-563.
-
(2003)
Carcinogenesis
, vol.24
, pp. 555-563
-
-
Singh, R.P.1
Agarwal, C.2
Agarwal, R.3
-
19
-
-
0034526276
-
Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells
-
Zi X, Singh RP, Agarwal R. Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells. Carcinogenesis 2000;21:2225-2235.
-
(2000)
Carcinogenesis
, vol.21
, pp. 2225-2235
-
-
Zi, X.1
Singh, R.P.2
Agarwal, R.3
-
20
-
-
0345305275
-
Inositol hexaphosphate inhibits constitutive activation of NF-kappa B in androgen-independent human prostate carcinoma DU145 cells
-
Agarwal C, Dhanalakshmi S, Singh RP, Agarwal R. Inositol hexaphosphate inhibits constitutive activation of NF-kappa B in androgen-independent human prostate carcinoma DU145 cells. Anticancer Res 2003;23:3855-3861.
-
(2003)
Anticancer Res
, vol.23
, pp. 3855-3861
-
-
Agarwal, C.1
Dhanalakshmi, S.2
Singh, R.P.3
Agarwal, R.4
-
21
-
-
1642453720
-
In vivo suppression of hormonerefractory prostate cancer growth by inositol hexaphosphate: Induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor
-
Singh RP, Sharma G, Mallikarjuna GU, Dhanalakshmi S, Agarwal C, Agarwal R. In vivo suppression of hormonerefractory prostate cancer growth by inositol hexaphosphate: Induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor. Clin Cancer Res 2004;10:244-250.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 244-250
-
-
Singh, R.P.1
Sharma, G.2
Mallikarjuna, G.U.3
Dhanalakshmi, S.4
Agarwal, C.5
Agarwal, R.6
-
22
-
-
3142745596
-
Growth inhibitory and apoptotic effects of inositol hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells
-
Sharma G, Singh RP, Agarwal R. Growth inhibitory and apoptotic effects of inositol hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells. Int J Oncol 2003;23:1413-1418.
-
(2003)
Int J Oncol
, vol.23
, pp. 1413-1418
-
-
Sharma, G.1
Singh, R.P.2
Agarwal, R.3
-
23
-
-
49649098564
-
Chemopreventive efficacy of inositol hexaphosphate against prostate tumor growth and progression in TRAMP mice
-
Raina K, Rajamanickam S, Singh RP, Agarwal R. Chemopreventive efficacy of inositol hexaphosphate against prostate tumor growth and progression in TRAMP mice. Clin Cancer Res 2008;14:3177-3184.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 3177-3184
-
-
Raina, K.1
Rajamanickam, S.2
Singh, R.P.3
Agarwal, R.4
-
25
-
-
0034668148
-
Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents
-
Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem Pharmacol 2000;60:1051-1059.
-
(2000)
Biochem Pharmacol
, vol.60
, pp. 1051-1059
-
-
Agarwal, R.1
-
26
-
-
1842471336
-
Signaling through the epidermal growth factor receptor during the development of malignancy
-
Grandis JR, Sok JC. Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol Ther 2004;102:37-46.
-
(2004)
Pharmacol Ther
, vol.102
, pp. 37-46
-
-
Grandis, J.R.1
Sok, J.C.2
-
27
-
-
33745112128
-
Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-kappaB in mouse epidermal JB6 cells
-
Singh RP, Dhanalakshmi S, Mohan S, Agarwal C, Agarwal R. Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-kappaB in mouse epidermal JB6 cells. Mol Cancer Ther 2006;5:1145-1153.
-
(2006)
Mol Cancer Ther
, vol.5
, pp. 1145-1153
-
-
Singh, R.P.1
Dhanalakshmi, S.2
Mohan, S.3
Agarwal, C.4
Agarwal, R.5
-
28
-
-
33845332401
-
Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines
-
Sharrard RM, Maitland NJ. Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines. Cell Signal 2007;19:129-138.
-
(2007)
Cell Signal
, vol.19
, pp. 129-138
-
-
Sharrard, R.M.1
Maitland, N.J.2
-
29
-
-
0024869513
-
AP1, a composite transcription factor implicated in abnormal growth control
-
Imler JL, Wasylyk B. AP1, a composite transcription factor implicated in abnormal growth control. Prog Growth Factor Res 1989;1:69-77.
-
(1989)
Prog Growth Factor Res
, vol.1
, pp. 69-77
-
-
Imler, J.L.1
Wasylyk, B.2
-
30
-
-
0038732463
-
Phytic acid (IP6), novel broad spectrum antineoplastic agent: A systematic review
-
Fox CH, Eberl M. Phytic acid (IP6), novel broad spectrum antineoplastic agent: A systematic review. Complement Ther Med 2002;10:229-234.
-
(2002)
Complement Ther Med
, vol.10
, pp. 229-234
-
-
Fox, C.H.1
Eberl, M.2
-
31
-
-
0025021262
-
Antioxidant functions of phytic acid
-
Graf E, Eaton JW. Antioxidant functions of phytic acid. Free Radic Biol Med 1990;8:61-69.
-
(1990)
Free Radic Biol Med
, vol.8
, pp. 61-69
-
-
Graf, E.1
Eaton, J.W.2
-
32
-
-
0032080609
-
A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells
-
Zi X, Grasso AW, Kung HJ, Agarwal R. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. Cancer Res 1998;58:1920-1929.
-
(1998)
Cancer Res
, vol.58
, pp. 1920-1929
-
-
Zi, X.1
Grasso, A.W.2
Kung, H.J.3
Agarwal, R.4
-
33
-
-
28544444712
-
Type I insulin-like growth factor receptor as a therapeutic target in cancer
-
Miller BS, Yee D. Type I insulin-like growth factor receptor as a therapeutic target in cancer. Cancer Res 2005;65:10123-10127.
-
(2005)
Cancer Res
, vol.65
, pp. 10123-10127
-
-
Miller, B.S.1
Yee, D.2
-
34
-
-
40349091247
-
Insulin, insulin-like growth factors, insulin resistance, and neoplasia
-
Pollack MN. Insulin, insulin-like growth factors, insulin resistance, and neoplasia. Am J Clin Nutr 2007;86:s820-s822.
-
(2007)
Am J Clin Nutr
, vol.86
-
-
Pollack, M.N.1
-
35
-
-
34248572839
-
MAP kinases and the control of nuclear events
-
Turjanski AG, Vaqué JP, Gutkind JS. MAP kinases and the control of nuclear events. Oncogene 2007;26:3240-3243.
-
(2007)
Oncogene
, vol.26
, pp. 3240-3243
-
-
Turjanski, A.G.1
Vaqué, J.P.2
Gutkind, J.S.3
-
36
-
-
34248597065
-
Differential regulation and properties of MAPKs
-
Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. Oncogene 2007;26:3100-3112.
-
(2007)
Oncogene
, vol.26
, pp. 3100-3112
-
-
Raman, M.1
Chen, W.2
Cobb, M.H.3
-
37
-
-
0035066383
-
Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation
-
Kyriakis JM, Avruch J.Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001;81:807-869.
-
(2001)
Physiol Rev
, vol.81
, pp. 807-869
-
-
Kyriakis, J.M.1
Avruch, J.2
|